| Year |
Citation |
Score |
| 2014 |
Alsante KM, Huynh-Ba K, Baertschi SW, Reed RA, Landis MS, Kleinman MH, Foti C, Rao VM, Meers P, Abend A, Reynolds DW, Joshi BK. Recent trends in product development and regulatory issues on impurities in active pharmaceutical ingredient (API) and drug products. Part 1: Predicting degradation related impurities and impurity considerations for pharmaceutical dosage forms. Aaps Pharmscitech. 15: 198-212. PMID 24281749 DOI: 10.1208/S12249-013-0047-X |
0.355 |
|
| 2012 |
Hemenway JN, Carvalho TC, Rao VM, Wu Y, Levons JK, Narang AS, Paruchuri SR, Stamato HJ, Varia SA. Formation of reactive impurities in aqueous and neat polyethylene glycol 400 and effects of antioxidants and oxidation inducers. Journal of Pharmaceutical Sciences. 101: 3305-18. PMID 22610374 DOI: 10.1002/jps.23198 |
0.69 |
|
| 2012 |
Desai D, Rao V, Guo H, Li D, Stein D, Hu FY, Kiesnowski C. An active film-coating approach to enhance chemical stability of a potent drug molecule. Pharmaceutical Development and Technology. 17: 227-35. PMID 21073265 DOI: 10.3109/10837450.2010.531737 |
0.386 |
|
| 2011 |
Rao VM, Zannou EA, Stella VJ. Design of tablets for the delayed and complete release of poorly water-soluble weak base drugs using SBE7M-β-CD as a solubilizing agent. Journal of Pharmaceutical Sciences. 100: 1576-87. PMID 24081477 DOI: 10.1002/Jps.22375 |
0.738 |
|
| 2011 |
Wu Y, Levons J, Narang AS, Raghavan K, Rao VM. Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility. Aaps Pharmscitech. 12: 1248-63. PMID 21948318 DOI: 10.1208/s12249-011-9677-z |
0.433 |
|
| 2011 |
Stella VJ, Rao VM, Zannou EA, Zia V. Erratum to “Mechanisms of drug release from cyclodextrin complexes” [Advanced Drug Delivery Reviews 36 (1999) 3–16] Advanced Drug Delivery Reviews. 63: 1371. DOI: 10.1016/J.Addr.2011.06.006 |
0.739 |
|
| 2009 |
Sotthivirat S, Haslam JL, Lee PI, Rao VM, Stella VJ. Release mechanisms of a sparingly water-soluble drug from controlled porosity-osmotic pump pellets using sulfobutylether-beta-cyclodextrin as both a solubilizing and osmotic agent. Journal of Pharmaceutical Sciences. 98: 1992-2000. PMID 18823032 DOI: 10.1002/Jps.21567 |
0.787 |
|
| 2009 |
Narang AS, Rao VM, Raghavan KS. Excipient Compatibility Developing Solid Oral Dosage Forms. 125-145. DOI: 10.1016/B978-0-444-53242-8.00006-0 |
0.482 |
|
| 2006 |
Rao VM, Nerurkar M, Pinnamaneni S, Rinaldi F, Raghavan K. Co-solubilization of poorly soluble drugs by micellization and complexation. International Journal of Pharmaceutics. 319: 98-106. PMID 16765542 DOI: 10.1016/j.ijpharm.2006.03.042 |
0.363 |
|
| 2004 |
Zhao F, Malayev V, Rao V, Hussain M. Effect of sodium lauryl sulfate in dissolution media on dissolution of hard gelatin capsule shells. Pharmaceutical Research. 21: 144-8. PMID 14984269 DOI: 10.1023/B:PHAM.0000012162.52419.b3 |
0.455 |
|
| 2003 |
Rao VM, Stella VJ. When can cyclodextrins be considered for solubilization purposes? Journal of Pharmaceutical Sciences. 92: 927-32. PMID 12712411 DOI: 10.1002/Jps.10341 |
0.604 |
|
| 2003 |
Rao VM, Engh K, Qiu Y. Design of pH-independent controlled release matrix tablets for acidic drugs. International Journal of Pharmaceutics. 252: 81-6. PMID 12550783 DOI: 10.1016/S0378-5173(02)00622-1 |
0.57 |
|
| 2002 |
Stella VJ, Rao VM, Zannou EA. The pharmaceutical use of Captisol®: Some surprising observations Journal of Inclusion Phenomena. 44: 29-33. DOI: 10.1023/A:1023068414272 |
0.739 |
|
| 2001 |
Rao VM, Haslam JL, Stella VJ. Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-beta-cyclodextrin as a solubilizing agent. Journal of Pharmaceutical Sciences. 90: 807-16. PMID 11458330 DOI: 10.1002/Jps.1034 |
0.657 |
|
| 1999 |
Stella VJ, Rao VM, Zannou EA, Zia V. Mechanisms of drug release from cyclodextrin complexes. Advanced Drug Delivery Reviews. 36: 3-16. PMID 10837705 DOI: 10.1016/S0169-409X(98)00052-0 |
0.744 |
|
| 1999 |
Stella VJ, Martodihardjo S, Terada K, Rao VM. Some relationships between the physical properties of various 3-acyloxymethyl prodrugs of phenytoin to structure: potential in vivo performance implications Journal of Pharmaceutical Sciences. 88: 1100. PMID 10514361 |
0.429 |
|
| 1999 |
Stella VJ, Martodihardjo S, Rao VM. Aqueous solubility and dissolution rate does not adequately predict in vivo performance: a probe utilizing some N-acyloxymethyl phenytoin prodrugs. Journal of Pharmaceutical Sciences. 88: 775-9. PMID 10430541 DOI: 10.1021/Js980489I |
0.559 |
|
| 1998 |
Stella VJ, Martodihardjo S, Terada K, Rao VM. Some relationships between the physical properties of various 3-acyloxymethyl prodrugs of phenytoin to structure: potential in vivo performance implications. Journal of Pharmaceutical Sciences. 87: 1235-41. PMID 9758683 DOI: 10.1021/Js980008V |
0.576 |
|
| 1997 |
Rao VM, Lin M, Larive CK, Southard MZ. A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions Journal of Pharmaceutical Sciences. 86: 1132-1137. PMID 9344170 DOI: 10.1021/Js9604974 |
0.476 |
|
| Show low-probability matches. |